LifeCycle Pharma A/S to Host Full Year 2007 Financial Results Conference Call

| Source: Veloxis Pharmaceuticals A/S Veloxis Pharmaceuticals A/S 

Investor Service Announcement no. 01/2008

To: OMX Nordic Exchange Copenhagen		Hørsholm, Denmark, February 26, 2008

LifeCycle Pharma A/S to Host Full Year 2007 Financial Results Conference Call
 
LifeCycle Pharma A/S (OMX: LCP), an emerging specialty pharmaceutical company,
will announce financial results for the full year ended December 31, 2007 after
the close of the Danish financial market on Thursday, February 28, 2008. LCP's
Executive Management will host an accompanying conference call to discuss the
financial results the following day, Friday, February 29, 2008 at 17:00 CET
(Denmark); 16:00 GMT (London); 11:00 a.m. ET (New York); 8:00 a.m. PT (San
Francisco). 

To access the live conference call, please dial one of the following numbers:
+1 71 835 412 26 (U.S.)
+44 208 817 9301 (UK)
+45 70 26 50 40 (DK)

An audio replay of the conference call will be available from 19:00 CET
(Denmark); 18:00 GMT (London); 01:00 p.m. ET (New York); 10:00 a.m. PT (San
Francisco) on Friday, February 29, 2008 through Friday, March 7, 2008 by
dialing +353 1 436 4267, and entering confirmation code 1183572#. 

Additionally, the audio webcast will be available on the Company's website,
www.lcpharma.com, for 30 days. The preliminary annual report will also be
accessible on the Company's website. The Annual Report will be available in
print and PDF-version April 7, 2008. 

About LCP
LCP is an emerging specialty pharmaceutical company, focused on certain
cardiovascular indications and the transplantation market in particular. The
intention is to approach the transplantation market through our own, hospital
based specialist sales force and to use marketing and sales partners for the
cardiovascular indications. We currently have one product on the market, seven
clinical development programs covering five product candidates and three
product candidates in pre-clinical development. LCP is listed on the OMX Nordic
Exchange under the trading symbol (OMX: LCP). For further information, please
visit www.lcpharma.com. 

For further information, please contact:

Flemming Ørnskov, MD 		Hans Christian Teisen
President and CEO 		         Senior Vice President
Tel.: +45 24 20 03 68 		Tel. +45 36 13 29 70
E-mail: fo@lcpharma.com 		E-mail: hct@lcpharma.com

Attachments

20080226-lcp to host full year 2007 financial results conference call.pdf